PT1265629E - Utilizacao da hormona de crescimento em dose baixa - Google Patents
Utilizacao da hormona de crescimento em dose baixaInfo
- Publication number
- PT1265629E PT1265629E PT01914289T PT01914289T PT1265629E PT 1265629 E PT1265629 E PT 1265629E PT 01914289 T PT01914289 T PT 01914289T PT 01914289 T PT01914289 T PT 01914289T PT 1265629 E PT1265629 E PT 1265629E
- Authority
- PT
- Portugal
- Prior art keywords
- growth hormone
- less
- low dose
- day
- therapy
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 4
- 108010051696 Growth Hormone Proteins 0.000 title abstract 4
- 239000000122 growth hormone Substances 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 2
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 2
- 239000000854 Human Growth Hormone Substances 0.000 abstract 2
- 206010022489 Insulin Resistance Diseases 0.000 abstract 2
- 230000002950 deficient Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0000837A SE0000837D0 (sv) | 2000-03-13 | 2000-03-13 | New use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1265629E true PT1265629E (pt) | 2006-09-29 |
Family
ID=20278800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01914289T PT1265629E (pt) | 2000-03-13 | 2001-03-13 | Utilizacao da hormona de crescimento em dose baixa |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6696414B2 (pt) |
| EP (1) | EP1265629B1 (pt) |
| JP (1) | JP2003526675A (pt) |
| AT (1) | ATE328604T1 (pt) |
| AU (1) | AU2001239635A1 (pt) |
| CA (1) | CA2402948A1 (pt) |
| DE (1) | DE60120371T2 (pt) |
| DK (1) | DK1265629T3 (pt) |
| ES (1) | ES2263601T3 (pt) |
| NZ (1) | NZ533844A (pt) |
| PT (1) | PT1265629E (pt) |
| SE (1) | SE0000837D0 (pt) |
| WO (1) | WO2001068127A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020165127A1 (en) * | 1996-12-24 | 2002-11-07 | Supergen, Inc. | Methods for treating insulin resistance and identifying patients at risk for the disease |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670393A (en) | 1982-03-22 | 1987-06-02 | Genentech, Inc. | DNA vectors encoding a novel human growth hormone-variant protein |
| US5079345A (en) * | 1988-08-19 | 1992-01-07 | Eli Lilly And Company | Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism |
| CA2345497A1 (en) | 1988-10-28 | 1990-04-28 | Genentech, Inc. | Growth hormone variants and method for forming growth hormone variants |
| JPH04503154A (ja) | 1988-11-07 | 1992-06-11 | ルニベルシー・ド・ルタ・ア・リージュ | 変型ヒト成長ホルモン |
| IT1251895B (it) | 1991-09-27 | 1995-05-26 | Eniricerche Spa | Mutanti dell'ormone della crescita umano e loro impiego |
| MD1486G2 (ro) | 1992-10-29 | 2001-11-30 | Genentech, Inc. | Metodă de tratament sau profilaxie a obezităţii |
| US5597709A (en) * | 1994-01-27 | 1997-01-28 | Human Genome Sciences, Inc. | Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| EP0766966A3 (en) * | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Method of treating insulin resistance |
| SE9601397D0 (sv) * | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
| PT1007085E (pt) | 1997-07-04 | 2002-05-31 | Pharmacia Ab | Utilizacao da hormona de crescimento em composicoes para o tratamento da resistencia a insulina no coracao |
-
2000
- 2000-03-13 SE SE0000837A patent/SE0000837D0/xx unknown
-
2001
- 2001-03-13 DE DE60120371T patent/DE60120371T2/de not_active Expired - Fee Related
- 2001-03-13 PT PT01914289T patent/PT1265629E/pt unknown
- 2001-03-13 ES ES01914289T patent/ES2263601T3/es not_active Expired - Lifetime
- 2001-03-13 DK DK01914289T patent/DK1265629T3/da active
- 2001-03-13 AT AT01914289T patent/ATE328604T1/de not_active IP Right Cessation
- 2001-03-13 EP EP01914289A patent/EP1265629B1/en not_active Expired - Lifetime
- 2001-03-13 WO PCT/SE2001/000522 patent/WO2001068127A1/en active IP Right Grant
- 2001-03-13 JP JP2001566691A patent/JP2003526675A/ja active Pending
- 2001-03-13 NZ NZ533844A patent/NZ533844A/en unknown
- 2001-03-13 CA CA002402948A patent/CA2402948A1/en not_active Abandoned
- 2001-03-13 AU AU2001239635A patent/AU2001239635A1/en not_active Abandoned
- 2001-03-13 US US09/804,775 patent/US6696414B2/en not_active Expired - Fee Related
-
2004
- 2004-01-21 US US10/761,505 patent/US7229965B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1265629B1 (en) | 2006-06-07 |
| ATE328604T1 (de) | 2006-06-15 |
| US7229965B2 (en) | 2007-06-12 |
| EP1265629A1 (en) | 2002-12-18 |
| NZ533844A (en) | 2007-11-30 |
| US20040147446A1 (en) | 2004-07-29 |
| JP2003526675A (ja) | 2003-09-09 |
| AU2001239635A1 (en) | 2001-09-24 |
| DE60120371T2 (de) | 2007-05-16 |
| DK1265629T3 (da) | 2006-08-28 |
| ES2263601T3 (es) | 2006-12-16 |
| WO2001068127A1 (en) | 2001-09-20 |
| DE60120371D1 (de) | 2006-07-20 |
| SE0000837D0 (sv) | 2000-03-13 |
| US6696414B2 (en) | 2004-02-24 |
| CA2402948A1 (en) | 2001-09-20 |
| US20010051601A1 (en) | 2001-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200001891T2 (tr) | ASPB28- İnsan ensülini ve kullanımı. | |
| BRPI0015284B8 (pt) | formulações de hidrocodona de liberação controlada | |
| ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
| IL145487A0 (en) | Apomorphine and sildenafil composition | |
| HK1088547A1 (en) | Once daily dosage forms of trospium trospium | |
| SG146638A1 (en) | Pharmaceutical delivery system | |
| HUP0300218A2 (hu) | Eljárás diabetes kezelésére, metformin és glybarid kombinációját alkalmazva | |
| BG104797A (en) | Use of dexmedetomi dine for sedative effect in patients in an intensive care unit | |
| CA2401000A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
| CO5251425A1 (es) | Metodo y composiciones para administrar taxanos oralmente a pacientes humanos | |
| JP2003514025A5 (pt) | ||
| JP2002540148A5 (pt) | ||
| IL173822A0 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| LT2006024A (en) | Tetrapeptide regulating blood glucose level in diabetes mellitus | |
| CA2450915A1 (en) | Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure | |
| TR200401810T4 (tr) | Kısırlık tedavisinde fsh'ın kullanılması | |
| KR100271087B1 (en) | Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia | |
| IL163091A (en) | Medical product and pharmaceutical composition comprising as active ingredients a thrombolytic agent and levosimendan or a pharmaceutically acceptable salt thereof and the use of same in the manufacture of medicament for reducing mortality of patients with acute myocardial infarction | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| PT1265629E (pt) | Utilizacao da hormona de crescimento em dose baixa | |
| TWI263502B (en) | Pharmaceutical preparation for treating ischemic disease of heart or limbs | |
| MXPA02009603A (es) | Terapias de dosis divididas con actividad de deterioro vascular. | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
| MD1568G2 (ro) | Metodă de tratament al bolii arşilor în perioada şocului combustional | |
| RU94000695A (ru) | Средство с противоаллергическим действием |